ÂÜÀòÂÒÂ×

Brian Heath is an accomplished executive in the biotechnology and pharmaceutical industry with over two decades of experience. Since March 2009, Brian has held several leadership positions at Amgen, including Vice President and General Manager of the US Oncology Business Unit and Amgen Canada, where contributions included leading initiatives and serving as Vice-Chair of the Board of Directors of Innovative Medicines Canada. Additional roles encompassed Executive Director of Marketing for Hematology, Oncology, and Biosimilars in the Intercontinental region, along with brand leadership for products such as KYPROLIS and BLINCYTO. Previously, Brian worked at Novian Health and Eli Lilly and Company, where responsibilities spanned from marketing management in oncology to global brand strategy in bone health. Brian holds an MBA from Harvard Business School and a BS in Plant Genetics from Brigham Young University.